Corrigendum to “Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells” (Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells (2009) 205(1) (126–134), (S002191500800779X), (10.1016/j.atherosclerosis.2008.11.011));Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells

Atherosclerosis

Volumn 205, Issue 1, 2009, Pages 126-134

  Brito, Paula M ^a   Devillard, Raphaël ^b   Nègre Salvayre, Anne ^b,c   Almeida, Leonor M ^a   Dinis, Teresa C P ^a   Salvayre, Robert ^b,c   Augé, Nathalie ^b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b CHU RANGUEIL   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Akt; Oxidized LDL; PDK1; Proliferation; Resveratrol; Smooth muscle cells

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; POLYPHENOL; PROTEIN KINASE B; RAPAMYCIN; RESVERATROL; S6 KINASE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

EID: 67349122064     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2019.03.018     Document Type: Erratum

References (36)

1. Lusis A.J. Atherosclerosis. Nature 407 (2000) 233-241
2. Berliner J.A., and Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 20 (1996) 707-727
3. Auge N., Escargueil-Blanc I., Lajoie-Mazenc I., et al. Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein. J Biol Chem 273 (1998) 12893-12900
4. Auge N., Negre-Salvayre A., Salvayre R., and Levade T. Sphingomyelin metabolites in vascular cell signaling and atherogenesis. Prog Lipid Res 39 (2000) 207-229
5. Auge N., Garcia V., Maupas-Schwalm F., Levade T., Salvayre R., and Negre-Salvayre A. Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways. Arterioscler Thromb Vasc Biol 22 (2002) 1990-1995
6. Nave B.T., Ouwens M., Withers D.J., Alessi D.R., and Shepherd P.R. Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J 344 Pt 2 (1999) 427-431
7. Shaw R.J., and Cantley LC. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441 (2006) 424-430
8. Sekulic A., Hudson C.C., Homme J.L., et al. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res 60 (2000) 3504-3513
9. Wullschleger S., Loewith R., and Hall M.N. TOR signaling in growth and metabolism. Cell 124 (2006) 471-484
10. Pace-Asciak C.R., Hahn S., Diamandis E.P., Soleas G., and Goldberg D.M. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 235 (1995) 207-219
11. Brito P., Almeida L.M., and Dinis T.C. The interaction of resveratrol with ferrylmyoglobin and peroxynitrite; protection against LDL oxidation. Free Radic Res 36 (2002) 621-631
12. Brito P.M., Mariano A., Almeida L.M., and Dinis T.C. Resveratrol affords protection against peroxynitrite-mediated endothelial cell death: a role for intracellular glutathione. Chem Biol Interact 164 (2006) 157-166
13. Ou H.C., Chou F.P., Sheen H.M., Lin T.M., Yang C.H., and Huey-Herng Sheu W. Resveratrol, a polyphenolic compound in red wine, protects against oxidized LDL-induced cytotoxicity in endothelial cells. Clin Chim Acta 364 (2006) 196-204
14. Ungvari Z., Orosz Z., Rivera A., et al. Resveratrol increases vascular oxidative stress resistance. Am J Physiol Heart Circ Physiol 292 (2007) H2417-2424
15. Tyagi A., Agarwal R., and Agarwal C. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis. Oncogene 22 (2003) 1302-1316
16. Godichaud S., Si-Tayeb K., Auge N., et al. The grape-derived polyphenol resveratrol differentially affects epidermal and platelet-derived growth factor signaling in human liver myofibroblasts. Int J Biochem Cell Biol 38 (2006) 629-637
17. Haider U.G., Sorescu D., Griendling K.K., Vollmar A.M., and Dirsch V.M. Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells. Mol Pharmacol 62 (2002) 772-777
18. Liu Y., and Liu G. Isorhapontigenin and resveratrol suppress oxLDL-induced proliferation and activation of ERK1/2 mitogen-activated protein kinases of bovine aortic smooth muscle cells. Biochem Pharmacol 67 (2004) 777-785
19. Tellier E., Negre-Salvayre A., Bocquet B., et al. Role for furin in tumor necrosis factor alpha-induced activation of the matrix metalloproteinase/sphingolipid mitogenic pathway. Mol Cell Biol 27 (2007) 2997-3007
20. Auge N., Pieraggi M.T., Thiers J.C., Negre-Salvayre A., and Salvayre R. Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells. Biochem J 309 Pt 3 (1995) 1015-1020
21. Vacaresse N., Vieira O., Robbesyn F., Jurgens G., Salvayre R., and Negre-Salvayre A. Phenolic antioxidants trolox and caffeic acid modulate the oxidized LDL-induced EGF-receptor activation. Br J Pharmacol 132 (2001) 1777-1788
22. Burgering B.M., Freed E., van der Voorn L., McCormick F., and Bos J.L. Platelet-derived growth factor-induced p21ras-mediated signaling is independent of platelet-derived growth factor receptor interaction with GTPase-activating protein or phosphatidylinositol-3-kinase. Cell Growth Differ 5 (1994) 341-347
23. Olson E.R., Naugle J.E., Zhang X., Bomser J.A., and Meszaro J.G. Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol. Am J Physiol Heart Circ Physiol 288 (2005) H1131-1138
24. Oak M.H., El Bedoui J., and Schini-Kerth V.B. Antiangiogenic properties of natural polyphenols from red wine and green tea. J Nutr Biochem 16 (2005) 1-8
25. Holme A.L., and Pervaiz S. Resveratrol in cell fate decisions. J Bioenerg Biomembr 39 (2007) 59-63
26. Zang M., Xu S., Maitland-Toolan K.A., et al. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 55 (2006) 2180-2191
27. Gwinn D.M., Shackelford D.B., Egan D.F., et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30 (2008) 214-226
28. Auge N., Maupas-Schwalm F., Elbaz M., et al. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. Circulation 110 (2004) 571-578
29. Frojdo S., Cozzone D., Vidal H., and Pirola L. Resveratrol is a class IA phosphoinositide 3-kinase inhibitor. Biochem J 406 (2007) 511-518
30. Haider U.G., Roos T.U., Kontaridis M.I., et al. Resveratrol inhibits angiotensin II- and epidermal growth factor-mediated Akt activation: role of Gab1 and Shp2. Mol Pharmacol 68 (2005) 41-48
31. Chan A.Y., Dolinsky V.W., Soltys C.L., et al. Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt. J Biol Chem 283 (2008) 24194-24201
32. Pozo-Guisado E., Lorenzo-Benayas M.J., and Fernandez-Salguero P.M. Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Int J Cancer 109 (2004) 167-173
33. Cullen J.P., Morrow D., Ji Y., et al. Resveratrol inhibits expression and binding activity of the monocyte chemotactic protein-1 receptor, CCR2, on THP-1 monocytes. Atherosclerosis 195 (2007) e125-133
34. Hill M.M., and Hemmings B.A. Inhibition of protein kinase B/Akt implications for cancer therapy. Pharmacol Ther 93 (2002) 243-251
35. Chao H.H., Juan S.H., Liu J.C., et al. Resveratrol inhibits angiotensin II-induced endothelin-1 gene expression and subsequent proliferation in rat aortic smooth muscle cells. Eur J Pharmacol 515 (2005) 1-9
36. Jung S.N., Yang W.K., Kim J., et al. Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells. Carcinogenesis 29 (2008) 713-721